Quick answer
This page lists 7 autologous bone marrow transplant doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Autologous Bone Marrow Transplant doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Autologous Bone Marrow Transplant doctors
FeaturedDr. Rahul Bhargava
MBBS, MD (General Medicine), DM (Clinical Hematology), Advanced Fellowship in Unrelated and Haploidentical Transplant
Principal Director & Chief – Hematology · Specialty: Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Hematologist & BMT Specialist
- Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram (2017 – Present)
- Head of Hematology and BMT, Artemis Hospital, Gurugram (2013 – 2016)
Expertise & Procedures
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical BMT
- Unrelated Donor BMT
- Peripheral Blood Stem Cell Transplantation
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Arun Singh Danewa
MBBS, MD (Pediatrics), Pediatric Oncology Training, Fellowship in Bone Marrow Transplantation
Sr. Consultant — Pediatric Hematology, Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Pediatric Hematologist & BMT Specialist
- Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram (Present)
- Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Haploidentical Stem Cell Transplant
- Matched Sibling Donor Transplant for Thalassemia
- Bone Marrow Aspiration & Biopsy
Pediatric Hematologist & BMT Specialist Experience: 10+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Anamika Bakliwal
MBBS, MD (Paediatrics), DM (Clinical Haematology — Adult & Paediatrics)
Consultant — Haemato-oncology & Bone Marrow Transplant · Specialty: Paediatric Haematologist & Bone Marrow Transplant Specialist
BLK-Max Super Speciality Hospital New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Paediatric Haematologist & Bone Marrow Transplant Specialist
- Consultant — Haemato-oncology & Bone Marrow Transplant, BLK-Max Super Speciality Hospital, New Delhi (Present)
- Senior Consultant, Sri Balaji Action Cancer Institute, Paschim Vihar, New Delhi
Expertise & Procedures
- Allogeneic bone marrow transplantation
- Autologous bone marrow transplantation
- Haploidentical bone marrow transplantation
- Peripheral blood stem cell mobilisation and collection
- Bone marrow aspiration and biopsy
Paediatric Haematologist & Bone Marrow Transplant Specialist Experience: 10+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Manisha Jain
MBBS, MD, DM
Senior Consultant — Hematology & Bone Marrow Transplant · Specialty: Hematologist & Bone Marrow Transplant Specialist
Medanta — The Medicity Gurgaon, India19+ Years experience
Why consider this doctor?
- 19+ years of experience in Hematologist & Bone Marrow Transplant Specialist
- Senior Consultant — Hematology & Bone Marrow Transplant, Medanta — The Medicity, Gurgaon, Present
- Consultant Hematologist, Artemis Hospital, Gurgaon
Expertise & Procedures
- Autologous Bone Marrow Transplantation
- Allogeneic Bone Marrow Transplantation
- Haploidentical Stem Cell Transplantation
- Matched Unrelated Donor (MUD) Transplant
- Bone Marrow Aspiration and Biopsy
Hematologist & Bone Marrow Transplant Specialist Experience: 19+ YearsHospital Affiliation: Medanta — The MedicityHospital accreditation: JCI, NABH
Dr. Neeraj Teotia
MBBS, MD, FNB, Fellowship in Pediatric Bone Marrow Transplant & Cellular Therapy
Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant · Specialty: Paediatric Haematologist and Bone Marrow Transplant Specialist
Marengo Asia Hospitals Gurugram, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Paediatric Haematologist and Bone Marrow Transplant Specialist
- Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant, Marengo Asia Hospitals, Gurugram, Present
- Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant, Marengo Asia Hospitals, Faridabad, Present
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Haploidentical Bone Marrow Transplant
- Matched Unrelated Donor Transplant
- Matched Sibling Donor Transplant
Paediatric Haematologist and Bone Marrow Transplant Specialist Experience: 10+ YearsHospital Affiliation: Marengo Asia HospitalsHospital accreditation: NABH, NABL
Dr. Priyanshi Pachauri
MBBS, MD, Clinical Hematology
Associate Consultant — Hemato-Oncology & BMT · Specialty: Hematologist
Fortis Hospital Noida, Delhi NCR, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Hematologist
- Associate Consultant, Hemato-Oncology & BMT, Fortis Hospital, Noida, Delhi NCR — Present
- Clinical training in Hematology, Christian Medical College (CMC), Vellore
Expertise & Procedures
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical Bone Marrow Transplant
- Matched Unrelated Donor Transplant
- Hematopoietic Stem Cell Transplant
Hematologist Experience: 10+ YearsHospital Affiliation: Fortis HospitalHospital accreditation: NABH, JCI
Dr. Rahul Naithani
MD, DM, Fellowship, FRCP
Chief of Hematology, Oncology & Bone Marrow Transplant · Specialty: Clinical Hematologist & Bone Marrow Transplant Specialist
Artemis Hospital Gurgaon, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Clinical Hematologist & Bone Marrow Transplant Specialist
- Chief of Hematology, Oncology & Bone Marrow Transplant — Artemis Hospital, Gurgaon, India — Present
- Senior Hematologist & BMT Specialist — Max Healthcare — Established the Hematology & Bone Marrow Transplant program (joined 2011)
Expertise & Procedures
- Allogeneic Bone Marrow Transplantation
- Autologous Bone Marrow Transplantation
- Haploidentical Bone Marrow Transplantation
- Unrelated Donor Stem Cell Transplantation
- Peripheral Blood Stem Cell Mobilization and Collection
Clinical Hematologist & Bone Marrow Transplant Specialist Experience: 15+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Gurgaon, IndiaStarting from$18,000
Artemis Hospital
Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Bone Marrow TransplantHematologyCardiac SurgeryCardiology
2+
Doctors for Autologous Bone Marrow Transplant
4.9
64 reviews
750+
Beds
19+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$18,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Bone Marrow TransplantHematologyCardiac SurgeryCardiology
1+
Doctors for Autologous Bone Marrow Transplant
3.8
48 reviews
650+
Beds
67+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$18,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Bone Marrow TransplantHematologyCardiac SurgeryCardiology
1+
Doctors for Autologous Bone Marrow Transplant
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 Sector 56, Gurgaon, IndiaStarting from$18,000
Marengo Asia Hospitals Gurgaon
Est. 1995
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Autologous Bone Marrow TransplantHematologyCardiac SurgeryCardiology
1+
Doctors for Autologous Bone Marrow Transplant
4.4
103 reviews
110+
Beds
31+
Years Since Founded
🇮🇳 Noida, IndiaStarting from$18,000
Fortis Hospital, Noida
Est. 2004
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Autologous Bone Marrow TransplantHematologyCardiac SurgeryCardiology
1+
Doctors for Autologous Bone Marrow Transplant
4.5
88 reviews
236+
Beds
22+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for multiple myeloma treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Autologous Bone Marrow Transplant?
Autologous Bone Marrow Transplant (also called Autologous Stem Cell Transplant) is a procedure in which a patient's own blood-forming stem cells are collected, stored, and reinfused after high-dose chemotherapy to rebuild healthy bone marrow. It is a standard consolidation treatment for eligible Multiple Myeloma patients who have responded to induction chemotherapy, aiming to deepen remission and prolong disease-free survival. The procedure is performed in a specialized transplant unit with close monitoring for infection and blood count recovery.
Who may be considered?
Autologous Bone Marrow Transplant may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Stem cells are mobilized with growth factors, collected via apheresis, cryopreserved, and reinfused after high-dose melphalan chemotherapy in a single transplant cycle.
2 approaches available for this procedure:
Autologous Peripheral Blood Stem Cell Transplant (Single Transplant)
Most PopularStem cells are mobilized with growth factors, collected via apheresis, cryopreserved, and reinfused after high-dose melphalan chemotherapy in a single transplant cycle.
Comprehensive Investigations
Estimated cost: $800 - $2,000
CBC, bone marrow biopsy/aspirate, serum protein electrophoresis, free light chain assay, kidney and liver function tests, ECG, echocardiogram, HLA typing (if applicable), infectious disease screening, PET-CT or MRI spine
Treatment / Procedure Estimate
Estimated cost in India: $18,000 - $30,000
Stay in India
Pre-procedure stay (outside hospital): ~3-5 days
Hospitalisation: ~18-21 days
Recovery period (outside hospital): ~30-45 days recommended
Total stay: approx 30-40 days
Usually Included in Hospital Package
- Stem cell mobilization and apheresis collection
- Cryopreservation and storage of stem cells
- High-dose conditioning chemotherapy
- Isolation room/transplant unit stay
- Post-transplant supportive care (transfusions, antibiotics, growth factors)
- Daily monitoring by transplant hematologist
Usually Not Included
- Pre-transplant induction chemotherapy cycles
- International/domestic travel and visa costs
- Accommodation for accompanying caregiver
- Long-term post-discharge medications
- Treatment of unexpected complications beyond standard package
Recovery and follow-up
Blood counts typically recover within 2-3 weeks post-transplant, after which patients are monitored as outpatients for infection risk, nutrition, and gradual return to normal activity over 2-3 months. Long-term follow-up includes periodic blood tests and myeloma marker monitoring to assess remission status.
Risks
Key risks include infection due to temporary immune suppression, mucositis, nausea, low blood counts requiring transfusions, and rarely organ toxicity from high-dose chemotherapy. Careful pre-transplant screening and supportive care in a specialized unit help minimize these risks.
Alternatives
Alternatives include continued conventional chemotherapy without transplant, allogeneic (donor) stem cell transplant for eligible high-risk patients, or newer targeted therapies such as CAR-T cell therapy and monoclonal antibodies where clinically appropriate. The suitability of each option depends on disease stage, patient fitness, and response to prior treatment.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Bone marrow biopsy and aspirate report confirming Multiple Myeloma
- Complete blood count (CBC) and comprehensive metabolic panel
- Serum/urine protein electrophoresis and free light chain assay
- PET-CT scan or MRI of spine/skeletal survey
- Cardiac evaluation (ECG, echocardiogram)
- Kidney and liver function test results
- Details of prior induction chemotherapy and response
- HLA typing report (if considering allogeneic backup option)
Patient information needed
- Current age, weight, and overall performance/functional status
- Stage of Multiple Myeloma at diagnosis and current disease status
- Number and type of prior chemotherapy cycles received
- Any known allergies or reactions to chemotherapy drugs
- Existing comorbidities (diabetes, heart, kidney, lung conditions)
- Current medications and supplements being taken
- Availability of a caregiver to stay during hospitalization
- Insurance coverage or planned mode of payment
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Autologous Bone Marrow Transplant) and procedure (Autologous Bone Marrow Transplant) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Autologous Bone Marrow Transplant in India
What is Multiple Myeloma?
Multiple myeloma is a cancer in which abnormal plasma cells accumulate in the bone marrow, producing excess proteins (called M-proteins or paraproteins) that can damage organs and disrupt normal blood cell production. It is considered a haematological malignancy and, while not currently curable in most cases, it is treatable and can often be managed effectively for many years.
What are the symptoms and health risks of Multiple Myeloma?
Common symptoms include persistent bone pain (particularly in the back, ribs, or hips), unexplained fatigue, frequent infections, easy bruising or bleeding, and signs of kidney problems such as increased thirst or reduced urine output. Some people experience numbness or weakness in the limbs if the disease affects the spine, and elevated calcium levels can cause confusion, nausea, or constipation. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of multiple myeloma.
How is Multiple Myeloma diagnosed?
Diagnosis typically involves blood and urine tests to detect abnormal proteins (including serum protein electrophoresis, immunofixation, and free light chain assay), a full blood count, kidney and calcium level checks, and bone marrow biopsy to confirm the presence and proportion of malignant plasma cells. Imaging — such as whole-body low-dose CT, MRI, or PET-CT — is used to assess bone involvement and detect lesions. Disease severity is stratified using established staging systems such as the Revised International Staging System (R-ISS), which incorporates albumin, beta-2 microglobulin, LDH levels, and cytogenetic risk markers to guide prognosis and treatment decisions.
How is Multiple Myeloma treated?
Treatment is highly individualised and depends on factors including disease stage, cytogenetic risk profile, the patient's age, fitness, and organ function. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation (using the patient's own stem cells) is a standard approach that can deepen and prolong remission. Alongside or instead of transplant, treatment may include combinations of targeted therapies (such as proteasome inhibitors or IMiDs), immunotherapy (including monoclonal antibodies), and conventional chemotherapy, with the specific regimen determined by a qualified specialist based on individual assessment.
Can Multiple Myeloma be treated without a procedure?
For patients who are not eligible for stem cell transplantation — due to age, fitness level, or other health conditions — effective non-procedural management is available using combinations of oral or intravenous targeted agents, immunotherapy, and chemotherapy. Supportive care measures, including bisphosphonates to protect bone health, growth factors to address anaemia, and prophylactic antibiotics to reduce infection risk, form an important part of ongoing management for all patients regardless of transplant eligibility. Active monitoring (sometimes called 'watch and wait') may be appropriate for asymptomatic precursor states such as smouldering myeloma, but this decision must be made by a specialist following careful individual assessment.
When is Autologous Bone Marrow Transplant considered for Multiple Myeloma?
Autologous Bone Marrow Transplant may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Multiple Myeloma?
Multiple myeloma is typically evaluated and managed by a haematologist or medical oncologist with specific expertise in haematological malignancies. For patients being considered for stem cell transplantation, care is coordinated through a specialist in bone marrow transplantation, usually within a multidisciplinary team that may also include nephrologists, radiologists, and specialist nurses.
How do I choose a doctor for Multiple Myeloma?
When selecting a specialist or facility, it is worth asking about the centre's volume and experience specifically in treating multiple myeloma, whether they offer access to a full multidisciplinary team, availability of novel and clinical-trial therapies, and what structured follow-up and relapse monitoring looks like over the long term.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.